先看重點
在韓國75名受試者中,11款消費級睡眠追蹤裝置與實驗室多導睡眠圖相比,睡眠分期一致性差異很大:宏平均F1分數最高為0.69,最低為0.26。受試者來自醫院和睡眠門診,結果未必等同於日常居家使用。
證據類型
測量驗證研究/回顧
解讀依據
公開摘要
閱讀重點
參照與測量誤差
研究在問什麼
很多人使用睡眠追蹤裝置,但很少有研究在同一大樣本中把多款熱門裝置與臨床標準相比。作者檢驗了穿戴式裝置、床邊裝置(nearable)和手機應用(airable)與多導睡眠圖(夜間睡眠實驗室記錄)的一致程度。
研究對象與方法
前瞻性多中心驗證研究,評估11款商用裝置:5款穿戴式裝置(Google Pixel Watch、Galaxy Watch 5、Fitbit Sense 2、Apple Watch 8、Oura Ring 3)、3款床邊裝置(Withings Sleep Tracking Mat、Google Nest Hub 2、Amazon Halo Rise)和3款手機應用(SleepRoutine、SleepScore、Pillow)。為避免裝置相互干擾,分為2組,每組(8款裝置)分別與多導睡眠圖對照。75名參與者來自韓國一家三級醫院和一家基層睡眠專科診所,以宏平均F1分數評價逐時段的睡眠分期一致性。
主要發現
以下為作者報告的結果。數值須連同族群和不確定性一起閱讀。
- 1共分析11款裝置的349,114個時段,收集到3890小時裝置睡眠記錄和543小時多導睡眠圖記錄。逐時段睡眠分期一致性差異很大,宏平均F1分數從0.26(最低)到0.69(最高)。
- 2分期表現上,SleepRoutine在清醒和快速眼動(REM)睡眠上表現最好,而Google Pixel Watch、Fitbit Sense 2等穿戴式裝置在深睡眠上表現更優。
- 3誤差與裝置型別有關:穿戴式裝置在睡眠效率上存在較高的比例偏倚,床邊裝置則在入睡潛伏期上存在較高的比例偏倚。
- 4宏平均F1分數隨BMI、睡眠效率和呼吸暫停低通氣指數而變化,男女之間差異很小。
限制與不確定性
- 1測試在醫院和睡眠門診進行,僅有75名參與者,日常居家睡眠的追蹤情況可能不同。
- 2摘要沒有說明哪款裝置得到0.69或0.26,除分期亮點外也未給出各裝置的具體數值。
- 3每組裝置僅作為8款裝置的整體與多導睡眠圖比較,不同組的裝置並非在同一夜佩戴。
- 4本解讀僅基於摘要。
日常健康啟示
不要預設所有裝置識別睡眠分期的能力相同;與睡眠實驗室的一致性差距很大。部分裝置與多導睡眠圖一致性較高,但分期準確性仍因裝置和個人睡眠情況而異。建議把分期資料當作粗略估計。
如何連結自己的資料
無論使用Oura Ring、Apple Watch、Fitbit還是床邊裝置,都建議用同一裝置觀察自己數週的夜間總量變化,而不要只看單夜的分期分鐘數。深睡眠、清醒時間和入睡潛伏期的估計因裝置而異,不同品牌的數值不宜直接比較。
如何理解這類證據
一致性取決於裝置、韌體、參照、族群和使用情境。相關性不等於一致性;驗證某個指標不等於已證明診斷或治療獲益。
作者的結構化摘要 English
以下英文摘要依所記錄的開放授權轉載,屬於作者原始材料,並非 MoveVitals 解讀。上方已提供研究解讀,分別說明作者結果與本站解釋;重要結論可直接查核原文。
Background
Consumer sleep trackers (CSTs) have gained significant popularity because they enable individuals to conveniently monitor and analyze their sleep. However, limited studies have comprehensively validated the performance of widely used CSTs. Our study therefore investigated popular CSTs based on various biosignals and algorithms by assessing the agreement with polysomnography.
Objective
This study aimed to validate the accuracy of various types of CSTs through a comparison with in-lab polysomnography. Additionally, by including widely used CSTs and conducting a multicenter study with a large sample size, this study seeks to provide comprehensive insights into the performance and applicability of these CSTs for sleep monitoring in a hospital environment.
Methods
The study analyzed 11 commercially available CSTs, including 5 wearables (Google Pixel Watch, Galaxy Watch 5, Fitbit Sense 2, Apple Watch 8, and Oura Ring 3), 3 nearables (Withings Sleep Tracking Mat, Google Nest Hub 2, and Amazon Halo Rise), and 3 airables (SleepRoutine, SleepScore, and Pillow). The 11 CSTs were divided into 2 groups, ensuring maximum inclusion while avoiding interference between the CSTs within each group. Each group (comprising 8 CSTs) was also compared via polysomnography.
Results
The study enrolled 75 participants from a tertiary hospital and a primary sleep-specialized clinic in Korea. Across the 2 centers, we collected a total of 3890 hours of sleep sessions based on 11 CSTs, along with 543 hours of polysomnography recordings. Each CST sleep recording covered an average of 353 hours. We analyzed a total of 349,114 epochs from the 11 CSTs compared with polysomnography, where epoch-by-epoch agreement in sleep stage classification showed substantial performance variation. More specifically, the highest macro F1 score was 0.69, while the lowest macro F1 score was 0.26. Various sleep trackers exhibited diverse performances across sleep stages, with SleepRoutine excelling in the wake and rapid eye movement stages, and wearables like Google Pixel Watch and Fitbit Sense 2 showing superiority in the deep stage. There was a distinct trend in sleep measure estimation according to the type of device. Wearables showed high proportional bias in sleep efficiency, while nearables exhibited high proportional bias in sleep latency. Subgroup analyses of sleep trackers revealed variations in macro F1 scores based on factors, such as BMI, sleep efficiency, and apnea-hypopnea index, while the differences between male and female subgroups were minimal.
Conclusions
Our study showed that among the 11 CSTs examined, specific CSTs showed substantial agreement with polysomnography, indicating their potential application in sleep monitoring, while other CSTs were partially consistent with polysomnography. This study offers insights into the strengths of CSTs within the 3 different classes for individuals interested in wellness who wish to understand and proactively manage their own sleep.
來源與署名
Accuracy of 11 Wearable, Nearable, and Airable Consumer Sleep Trackers: Prospective Multicenter Validation Study.
Lee T, Cho Y, Cha KS, Jung J, Cho J, Kim H, Kim D, Hong J, Lee D, Keum M, Kushida CA, Yoon IY, Kim JW.
JMIR mHealth and uHealth · 2023-11-02
DOI: 10.2196/50983 ↗PubMed · 37917155 ↗Europe PMC · 所記錄的開放授權: cc by ↗摘要著作權歸原作者,依來源紀錄的開放授權轉載。中文譯文協助閱讀,英文摘要供查核術語及具體數值;本站的方法學解釋與作者結論分別呈現。
MoveVitals 編輯解讀 · 健康教育內容 · 未記錄個人臨床審閱
來源查核日期 2026-11-01
實用健康指南
放在一起讀
運動改善45歲及以上睡眠障礙者的睡眠質量評分
彙總23項隨機對照試驗、共1,478名45至77歲睡眠障礙成年人的資料,運動改善了匹茲堡睡眠質量指數評分(SMD 0.62,95%置信區間0.40–0.83),網路分析中有氧運動效果最大(SMD 1.34,95%可信區間0.86–1.82)。證據確定性為低到中等,結局是問卷評分,每週約539 MET-min的最佳劑量是模型估計值,不是處方。
Journal of Exercise Science & Fitness
睡眠規律性比睡眠時長更能預測英國成年人的死亡風險
在60,977名佩戴腕式加速度計一週的英國生物樣本庫成年人中,睡眠最規律的五分之一族群,經完全校正後的全因死亡風險比為0.70(95%置信區間0.59–0.83),對照為最不規律的五分之一,追蹤約6.3年,共1859人死亡。規律性對資料的擬合優於睡眠時長,但這是隻依據一週資料的觀察性研究。
Sleep
延長睡眠使超重成年人每日能量攝取減少約270千卡
在80名平時睡眠不足6.5小時的超重成年人中,兩週的延長睡眠指導使睡眠增加約1.2小時,實測能量攝取比對照組少270.4千卡/天(95%置信區間−393.4至−147.4)。這是一項為期短、單中心、族群較窄的試驗,不能說明體重會持續下降,也不能說明對睡眠本就充足的人有益。
JAMA Internal Medicine
50歲和60歲時每晚睡6小時及以下,與日後失智風險較高相關
在7959名英國公務員中追蹤約25年,50歲時每晚睡6小時及以下者的失智風險比為1.22(95%置信區間1.01–1.48),60歲時為1.37(1.10–1.72),均高於睡7小時者;長期持續睡眠偏短者為1.30(1.00–1.69)。睡眠主要靠自報,且為觀察性研究,早期腦部病變等因素可能解釋了部分關聯。
Nature Communications

